Posterior Uveitis – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034

Posterior Uveitis Market Outlook

Thelansis’s “Posterior Uveitis Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Posterior Uveitis treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

Posterior Uveitis Overview

Posterior uveitis, a group of disorders characterized by diffuse choroidal inflammation, has multiple risk factors, including genetics, race, geography, and environment. The presence of specific major histocompatibility haplotypes in certain uveitis entities highlights the crucial role of genetic factors in its development. The classification of posterior uveitis into infectious and non-infectious categories is based on the underlying causes; fungal, bacterial, and viral infections (e.g. Candidiasis, Syphilis, Herpes zoster virus, Herpes simplex virus, and Cytomegalovirus) for infectious posterior uveitis and autoimmune diseases (e.g. Lupus erythematosus, White dot syndrome, Wegener granulomatosis, and Sarcoidosis) for non-infectious posterior uveitis. Through its cellular and humoral components, the immune system plays a crucial role in the inflammatory response aimed at removing causes of injury and by-products of injury. Prolonged or inappropriately directed inflammation can cause damage to normal body tissues, leading to disease and morbidity, including permanent visual morbidity commonly caused by recurrent inflammation or prolonged disease (e.g. cystoid macular edema, cataract, glaucoma, retinal detachment, and chorioretinal scarring).

 

Geography coverage:

G8 (United States, EU5 [France, Germany, Italy, Spain, U.K.], Japan, and China)

Insights driven by robust research, including:

• In-depth interviews with leading KOLs and payers
• Physician surveys
• RWE analysis for claims and EHR datasets
• Secondary research (e.g., peer-reviewed journal articles, third-party research databases)

Deliverables format and updates*:

• Detailed Report (PDF)
• Market Forecast Model (MS Excel-based automated dashboard)
• Epidemiology (MS Excel; interactive tool)
• Executive Insights (PowerPoint presentation)
• Others: regular updates, customizations, consultant support

*As per Thelansis’s policy, we ensure that we include all the recent updates before releasing the report content and market model.

Salient features of Market Forecast model:

• 10-year market forecast (2024–2034)
• Bottom-up patient-based market forecasts validated through the top-down sales methodology
• Covers clinically and commercially-relevant patient populations/ line of therapies
• Annualized drug-level sales and patient share projections
• Utilizes our proprietary Epilansis and Analog tool (e.g., drug uptake and erosion) datasets and conjoint analysis approach
• Detailed methodology/sources & assumptions
• Graphical and tabular outputs
• Users can customize the model based on requirements

Key business questions answered:

• How can drug development and lifecycle management strategies be optimized across G8 markets (US, EU5, Japan, and China)?
• How large is the patient population in terms of incidence, prevalence, segments, and those receiving drug treatments?
• What is the 10-year market outlook for sales and patient share?
• Which events will have the greatest impact on the market’s trajectory?
• What insights do interviewed experts provide on current and emerging treatments?
• Which pipeline products show the most promise, and what is their potential for launch and future positioning?
• What are the key unmet needs and KOL expectations for target profiles?
• What key regulatory and payer requirements must be met to secure drug approval and favorable market access?
• and more…

Read more: Posterior Uveitis – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034